LAZARD ASSET MANAGEMENT LLC - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 14 filers reported holding UNITED THERAPEUTICS CORP DEL in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q4 2014$22,326,000
-12.7%
8,250,000
-13.2%
0.05%
-12.7%
Q3 2014$25,560,000
+81.0%
9,500,000
+26.7%
0.06%
+83.3%
Q2 2014$14,123,0007,500,0000.03%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q1 2015
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders